Issue Date | Title | Author(s) |
2015 | Addressing the interplay between apoptosis and glucose metabolism in liver cirrhosis and hcc | Iansante, V; Choy, PM; Chokshi, S; Williams, R; Anders, RA; Bubici, C; Papa, S |
12-Jul-2019 | ASKing No More: The Emerging Role of Dual-Specific Phosphatase 12 in the Regulation of Hepatic Lipid Metabolism | Bubici, C; Lepore, A; Papa, S |
15-May-2019 | Editorial: The Warburg effect regulation under siege: The intertwined pathways in health and disease | Bubici, C; Papa, S |
2018 | The ERK and JNK pathways in the regulation of metabolic reprogramming. | Papa, S; Choy, PM; Bubici, C |
2018 | Feeding the Hedgehog: A new meaning for JNK signalling in liver regeneration | Papa, S; Bubici, C |
31-Oct-2018 | High expression of glycolytic genes in Cirrhosis correlates with the risk of developing liver cancer | Lee, NCW; Carella, MA; Papa, S; Bubici, C |
2015 | Increased aerobic glycolysis is associated with poor outcome and suppression of apoptosis in human liver cirrhosis and hcc | Iansante, V; Choy, PM; Chokshi, S; Williams, R; Anders, RA; Bubici, C; Papa, S |
2015 | Inhibition of mapk signalling promotes cell cycle arrest and sensitises intrahepatic cholangiocarcinoma cells to chemotherapy | Choy, PM; Sufi, J; Glaser, S; Alpini, G; Heaton, N; Williams, R; Quaglia, A; Syn, W-K; Bubici, C; Papa, S |
1-Jun-2023 | An Integrated Methodology to Quantify the Glycolytic Stress in Plasma Cell Myeloma in Response to Cytotoxic Drugs | Lepore, A; Kaci, FN; Bubici, C; Papa, S |
2014 | JNK signalling in cancer: In need of new, smarter therapeutic targets | Bubici, C; Papa, S |
4-Apr-2016 | Linking apoptosis to cancer metabolism: Another missing piece of JuNK. | Papa, S; Bubici, C |
2015 | PARP14 promotes the warburg effect in hepatocellular carcinoma by inhibiting JNK1-dependent PKM2 phosphorylation and activation | Iansante, V; Choy, PM; Fung, SW; Liu, Y; Chai, J-G; Dyson, J; Del Rio, A; D'Santos, C; Williams, R; Chokshi, S; Anders, RA; Bubici, C; Papa, S |
28-May-2021 | Phosphorylation and stabilization of PIN1 by JNK promote intrahepatic cholangiocarcinoma growth | Lepore, A; Choy, PM; Lee, NCW; Carella, MA; Favicchio, R; Briones‐Orta, MA; Glaser, SS; Alpini, G; D’Santos, C; Tooze, RM; Lorger, M; Syn, W; Papakyriakou, A; Giamas, G; Bubici, C; Papa, S |
2013 | Poly(ADP-ribose) polymerase family member 14 (PARP14) is a novel effector of the JNK2-dependent pro-survival signal in multiple myeloma | Barbarulo, A; Iansante, V; Chaidos, A; Naresh, K; Rahemtulla, A; Franzoso, G; Karadimitris, A; Haskard, DO; Papa, S; Bubici, C |
1-Jun-2023 | Screening Kinase-Dependent Phosphorylation of Key Metabolic Reprogramming Regulators | Kaci, FN; Lepore, A; Papa, S; Bubici, C |
Dec-2021 | STARD1: a new rising StAR in cholesterol-mediated hepatocarcinogenesis | Papa, S; Bubici, C; Syn, W-K |
2014 | Upregulation of a novel protein in hcc enhances cancer cell survival by suppressing specific apoptotic effectors | Iansante, V; Choy, PM; Fung, SW; Chai, J-G; Dyson, J; Liu, Y; Williams, R; Chokshi, S; Anders, RA; Bubici, C; Papa, S |